<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dysregulated expression of microRNAs (miRNA) is a hallmark of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>miR-16 has been reported to be downregulated and to act as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we sought to investigate the possible roles and mechanisms of miR-16 and its relationship with p53 and survivin in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>We showed that miR-16 was downregulated in 67% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues and was correlated with the degree of histological differentiation </plain></SENT>
<SENT sid="4" pm="."><plain>Experiments in vitro showed that overexpression of miR-16 inhibited the proliferation and induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells through the intrinsic <z:mpath ids='MPATH_3'>apoptosis</z:mpath> pathway </plain></SENT>
<SENT sid="5" pm="."><plain>We further showed that miR-16 repressed survivin expression at both the <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels and the survivin gene was a direct target of miR-16 </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, miR-16 reduced p53 expression and p53 increased miR-16 levels, with downregulation of miR-16 targets survivin, cyclin D1 and CDK6 </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings suggest that miR-16 represses <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell growth in vitro by regulating the p53/survivin signaling pathway </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings provide further evidence for the involvement of dysregulated miRNAs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and miR-16 could serve as a molecular target for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> therapy </plain></SENT>
</text></document>